» Articles » PMID: 11888897

Inhibition of Cancer Cell Growth by BRCA2

Overview
Journal Cancer Res
Specialty Oncology
Date 2002 Mar 13
PMID 11888897
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The breast cancer susceptibility gene BRCA2 has been suggested to function as a "caretaker" of the genome. Cells without wild-type BRCA2 are deficient in repairing DNA damage. However, whether BRCA2 can also suppress oncogenesis by regulating cell proliferation remains to be determined. To address this question, the expression of wild-type BRCA2 protein was reconstituted, in an either constitutive or regulated manner, in the pancreatic cancer cell line Capan-1, which expresses only a mutant BRCA2. Expression of wild-type BRCA2 inhibited cell proliferation in culture and suppressed tumor growth in animals. Our results showed that, in addition to the DNA repair function, BRCA2 also suppresses tumor development by inhibiting cancer cell growth.

Citing Articles

Tracing back primed resistance in cancer via sister cells.

Dai J, Zheng S, Falco M, Bao J, Eriksson J, Pikkusaari S Nat Commun. 2024; 15(1):1158.

PMID: 38326354 PMC: 10850087. DOI: 10.1038/s41467-024-45478-7.


TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of Mutation Status.

Ben Khaled N, Hammer K, Ye L, Alnatsha A, Widholz S, Piseddu I Cancers (Basel). 2022; 14(21).

PMID: 36358659 PMC: 9655638. DOI: 10.3390/cancers14215240.


Dipeptidyl peptidase 9 triggers BRCA2 degradation and promotes DNA damage repair.

Bolgi O, Silva-Garcia M, Ross B, Pilla E, Kari V, Killisch M EMBO Rep. 2022; 23(10):e54136.

PMID: 35912982 PMC: 9535758. DOI: 10.15252/embr.202154136.


Homologous Recombination-Enhancing Factors Identified by Comparative Transcriptomic Analyses of Pluripotent Stem Cell of Human and Common Marmoset.

Yoshimatsu S, Nakajima M, Qian E, Sanosaka T, Sato T, Okano H Cells. 2022; 11(3).

PMID: 35159172 PMC: 8834151. DOI: 10.3390/cells11030360.


A Validated Functional Analysis of Partner and Localizer of BRCA2 Missense Variants for Use in Clinical Variant Interpretation.

Brnich S, Arteaga E, Wang Y, Tan X, Berg J J Mol Diagn. 2021; 23(7):847-864.

PMID: 33964450 PMC: 8491091. DOI: 10.1016/j.jmoldx.2021.04.010.